ArticleTargeted oncology2024

Pembrolizumab in Patients with Advanced Urothelial Carcinoma with ECOG Performance Status 2: A Real-World Study from the ARON-2 Project.

Alessandro Rizzo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.